ADA activity and dATP levels in erythrocytes after bone marrow transplantation

Advances in Experimental Medicine and Biology

Volumn 486, Issue , 2000, Pages 51-55

  Fairbanks, L D ^a   Simmonds, H A ^a   Duley, J A ^a   Gaspar, H B ^b   Flood, T ^c   Steward, C A ^a,d  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REPLACEMENT; HUMAN; PRIORITY JOURNAL; PURINE METABOLISM; TREATMENT OUTCOME;

ADENOSINE DEAMINASE; BONE MARROW TRANSPLANTATION; DEOXYADENINE NUCLEOTIDES; ERYTHROCYTES; HUMANS; SEVERE COMBINED IMMUNODEFICIENCY; TREATMENT OUTCOME;

EID: 0034473787     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. A role for purine metabolism in the immune response: Adenosine deaminase activity and deoxyadenosine catabolism
2. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiencies. Chapter 52
3. Adult onset immunodeficiency due to adenosine deaminase deficiency
4. European experience of bone-marrow transplantation for severe combined immunodeficiency
5. Genetic disorders of purine and pyrimidine metabolism: Problems of diagnosis